Global RNAi for Therapeutic Consumption Market 2017 Industry Trend and Forecast 2021 is a new market research publication announced by Reportstack. This report is a professional and in-depth study on the current state of the RNAi for Therapeutic market
The report provides a basic overview of the RNAi for Therapeutic industry including definitions, classifications, applications and industry chain structure.
Development policies and plans are discussed as well as manufacturing processes are also analyzed.
Complete report available @ Global RNAi for Therapeutic Consumption Market 2017 Industry Trend and Forecast 2021
The report then analyzes the global RNAi for Therapeutic expenses, and the sales segment market is also discussed by product type, applications and region.
The major RNAi for Therapeutic market (including United States, Europe, etc.) is analyzed, data including market size, expenses segment market by product type and applications. Then we forecast the 2016-2025 market size of RNAi for Therapeutic.
The report focuses on global major leading companies providing information such as company profiles, expenses, R&D expenses and contact information.
Finally the marketing, feasibility of new investment projects are assessed and overall research conclusions offered.
Snapshot of TOC with Companies Mentioned
9 Analysis of RNAi for Therapeutic Industry Key Manufacturers 63
9.1 Alnylam Pharmaceuticals 63
9.1.1 Company Profile 63
9.1.2 Research Information 64
9.1.3 Expenses, R&D Expenses and R&D Share 64
9.2 Arbutus Biopharma (Tekmira) 66
9.2.1 Company Profile 66
9.2.2 Research Information 66
9.2.3 Expenses, R&D Expenses and R&D Share 67
9.3 Arrowhead Research 69
9.3.1 Company Profile 69
9.3.2 Research Information 70
9.3.3 Expenses, R&D Expenses and R&D Share 70
9.4 Dicerna Pharmaceuticals 72
9.4.1 Company Profile 72
9.4.2 Research Information 73
9.4.3 Expenses, R&D Expenses and R&D Share 73
9.5 Mirna Therapeutics 75
9.5.1 Company Profile 75
9.5.2 Research Information 76
9.5.3 Expenses, R&D Expenses and R&D Share 76
9.6 Quark Pharmaceuticals 78
9.6.1 Company Profile 78
9.6.2 Research Information 79
9.6.3 Expenses, R&D Expenses and R&D Share 79
9.7 RXi Pharmaceuticals 81
9.7.1 Company Profile 81
9.7.2 Research Information 82
9.7.3 Expenses, R&D Expenses and R&D Share 83
9.8 Silence Therapeutics 84
9.8.1 Company Profile 84
9.8.2 Research Information 85
9.8.3 Expenses, R&D Expenses and R&D Share 86
9.9 Benitec Biopharma 87
9.9.1 Company Profile 87
9.9.2 Research Information 88
9.9.3 Expenses, R&D Expenses and R&D Share 88
9.10 miRagen Therapeutics 90
9.10.1 Company Profile 90
9.10.2 Research Information 91
9.10.3 Expenses, R&D Expenses and R&D Share 92
9.11 Sylentis 93
9.11.1 Company Profile 93
9.11.2 Research Information 94
9.11.3 Expenses, R&D Expenses and R&D Share 95
9.12 Gradalis 96
9.12.1 Company Profile 96
9.12.2 Research Information 97
9.12.3 Expenses, R&D Expenses and R&D Share 97
9.13 Sirnaomics 99
9.13.1 Company Profile 99
9.13.2 Research Information 100
9.13.3 Expenses, R&D Expenses and R&D Share 100
9.14 Silenseed 102
9.14.1 Company Profile 102
9.14.2 Research Information 103
9.14.3 Expenses, R&D Expenses and R&D Share 103
9.1 Alnylam Pharmaceuticals 63
9.1.1 Company Profile 63
9.1.2 Research Information 64
9.1.3 Expenses, R&D Expenses and R&D Share 64
9.2 Arbutus Biopharma (Tekmira) 66
9.2.1 Company Profile 66
9.2.2 Research Information 66
9.2.3 Expenses, R&D Expenses and R&D Share 67
9.3 Arrowhead Research 69
9.3.1 Company Profile 69
9.3.2 Research Information 70
9.3.3 Expenses, R&D Expenses and R&D Share 70
9.4 Dicerna Pharmaceuticals 72
9.4.1 Company Profile 72
9.4.2 Research Information 73
9.4.3 Expenses, R&D Expenses and R&D Share 73
9.5 Mirna Therapeutics 75
9.5.1 Company Profile 75
9.5.2 Research Information 76
9.5.3 Expenses, R&D Expenses and R&D Share 76
9.6 Quark Pharmaceuticals 78
9.6.1 Company Profile 78
9.6.2 Research Information 79
9.6.3 Expenses, R&D Expenses and R&D Share 79
9.7 RXi Pharmaceuticals 81
9.7.1 Company Profile 81
9.7.2 Research Information 82
9.7.3 Expenses, R&D Expenses and R&D Share 83
9.8 Silence Therapeutics 84
9.8.1 Company Profile 84
9.8.2 Research Information 85
9.8.3 Expenses, R&D Expenses and R&D Share 86
9.9 Benitec Biopharma 87
9.9.1 Company Profile 87
9.9.2 Research Information 88
9.9.3 Expenses, R&D Expenses and R&D Share 88
9.10 miRagen Therapeutics 90
9.10.1 Company Profile 90
9.10.2 Research Information 91
9.10.3 Expenses, R&D Expenses and R&D Share 92
9.11 Sylentis 93
9.11.1 Company Profile 93
9.11.2 Research Information 94
9.11.3 Expenses, R&D Expenses and R&D Share 95
9.12 Gradalis 96
9.12.1 Company Profile 96
9.12.2 Research Information 97
9.12.3 Expenses, R&D Expenses and R&D Share 97
9.13 Sirnaomics 99
9.13.1 Company Profile 99
9.13.2 Research Information 100
9.13.3 Expenses, R&D Expenses and R&D Share 100
9.14 Silenseed 102
9.14.1 Company Profile 102
9.14.2 Research Information 103
9.14.3 Expenses, R&D Expenses and R&D Share 103
Contact:
Debora White
Manager - Marketing
Ph: +1-888-789-6604
ReportstackMarket Research
###
No comments:
Post a Comment